BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 25, 2007
View Archived Issues
Gilead Sciences reports progress of first quarter
Read More
Phase III studies show efficacy and safety of ferumoxytol iron replacement therapy
Read More
Recent GSK patent divulges novel therapeutic agent for atopic dermatitis
Read More
Improvements seen in type 2 diabetes patients given liraglutide
Read More
Etravirine demonstrates short-term efficacy in resistant HIV-1 infection
Read More
AstraZeneca to acquire MedImmune
Read More
Daiichi Sankyo to transfer all Daiichi Fine Chemical shares to Kyowa Hakko
Read More
Novel treatment options for HCV infection reported in recent GSK patents
Read More
Japanese submission for Glufast in combination with insulin sensitizer
Read More
R3 antibody shows efficacy in pancreatic cancer model
Read More
Phase IIa biomarker study investigates HF-0220 in mild to moderate Alzheimer's
Read More
Pharmion advances oral azacitidine in phase I
Read More
Actavis completes acquisition of Abrika
Read More
Enrollment completed in phase III study of Cerepro
Read More
Recent 3M and Obihiro University patents disclose new antiinfective agents
Read More
GGTase I inhibitor and prodrug profiled at AACR annual meeting
Read More
In vivo antitumor activity of novel anti-IGF-1R antibody reported by Schering-Plough
Read More
Nippon Shinyaku discontinues development of NS-9
Read More
FDA accepts Xcytrin NDA for filing
Read More
Approvable letter for bazedoxifene in prevention of postmenopausal osteoporosis
Read More
Maraviroc recommended for accelerated approval
Read More
Roche files Avastin and Xeloda submissions in Europe
Read More
New phase I trial studies NPI-0052 in multiple myeloma
Read More
Synosia in-licenses rufinamide for anxiety disorders and bipolar mood disorders
Read More
